Needs assessment and expected educational outcome
Nonclinical and clinical scientists will receive education around two of the most exciting and significant findings in cardiovascular science over the previous 12 months. Topics will include single cell RNA sequencing in atherosclerosis and new therapeutic opportunities to slow atheroprogression.
An update on the most exciting and significant basic vascular biology research of 2020. This will also be an opportunity to promote CBCS activities, particularly the FCVB 2022 meeting to be held in Budapest, and a CBCS manuscript summarising vascular biology breakthroughs of 2020 (under review by Cardiovascular Research). The webinar will be an opportunity to promote Cardiovascular Research.